BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 12660343)

  • 1. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
    Tsai HM
    J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets: thrombotic thrombocytopenic purpura.
    George JN; Sadler JE; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
    Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
    Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor and thrombotic thrombocytopenic purpura.
    Raife TJ; Montgomery RR
    Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe ADAMTS-13 deficiency in childhood.
    Schneppenheim R; Budde U; Hassenpflug W; Obser T
    Semin Hematol; 2004 Jan; 41(1):83-9. PubMed ID: 14727263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
    Suvajdzić-Vuković N
    Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.